Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kabos

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
Molecular Cancer Therapeutics|November 3, 2021
Triple Targeting of Breast Tumors Driven by Hormonal Receptors and HER2Elena Shagisultanova, Lyndsey S Crump, Michelle Borakove, et al.
Nucleic Acids Research|November 8, 2025
Maf1 cooperates with progesterone receptor to repress RNA polymerase III transcription of select tRNAsJessica Finlay-Schultz, Kiran Vinod Paul, Benjamin Erickson, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Maf1 Cooperates with Progesterone Receptor to Repress RNA Polymerase III Transcription of Select tRNAsJessica Finlay-Schultz, Kiran V Paul, Benjamin Erickson, et al.
Cancer Research|July 22, 2017
Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase IIIJessica Finlay-Schultz, Austin E Gillen, Heather M Brechbuhl, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Metabolic Switch in Endocrine Resistant Estrogen Receptor Positive Breast CancerHeather M Brechbuhl, Amy Han, Kiran Vinod Paul, et al.
Breast Cancer Research : BCR|July 7, 2012
Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathwaysRitsuko Iwanaga, Chu-An Wang, Douglas S Micalizzi, et al.
Cancers|April 12, 2022
Estrogens and Progestins Cooperatively Shift Breast Cancer Cell MetabolismAshley V Ward, Shawna B Matthews, Lynsey M Fettig, et al.
Oncology (Williston Park, N.Y.)|December 18, 2016
Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing StrategiesLinda Overholser, Elena Shagisultanova, Rachel A Rabinovitch, et al.
Breast Cancer Research and Treatment|July 24, 2012
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signaturesPeter Kabos, Jessica Finlay-Schultz, Chunling Li, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Short-term Topiramate treatment prevents radiation-induced cytotoxic edema in preclinical models of breast-cancer brain metastasisMaria J Contreras-Zárate, Karen Lf Alvarez-Eraso, Jenny A Jaramillo-Gómez, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Molecular Cancer Therapeutics|November 3, 2021
Triple Targeting of Breast Tumors Driven by Hormonal Receptors and HER2Elena Shagisultanova, Lyndsey S Crump, Michelle Borakove, et al.
Nucleic Acids Research|November 8, 2025
Maf1 cooperates with progesterone receptor to repress RNA polymerase III transcription of select tRNAsJessica Finlay-Schultz, Kiran Vinod Paul, Benjamin Erickson, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Maf1 Cooperates with Progesterone Receptor to Repress RNA Polymerase III Transcription of Select tRNAsJessica Finlay-Schultz, Kiran V Paul, Benjamin Erickson, et al.
Cancer Research|July 22, 2017
Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase IIIJessica Finlay-Schultz, Austin E Gillen, Heather M Brechbuhl, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Metabolic Switch in Endocrine Resistant Estrogen Receptor Positive Breast CancerHeather M Brechbuhl, Amy Han, Kiran Vinod Paul, et al.
Breast Cancer Research : BCR|July 7, 2012
Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathwaysRitsuko Iwanaga, Chu-An Wang, Douglas S Micalizzi, et al.
Cancers|April 12, 2022
Estrogens and Progestins Cooperatively Shift Breast Cancer Cell MetabolismAshley V Ward, Shawna B Matthews, Lynsey M Fettig, et al.
Oncology (Williston Park, N.Y.)|December 18, 2016
Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing StrategiesLinda Overholser, Elena Shagisultanova, Rachel A Rabinovitch, et al.
Breast Cancer Research and Treatment|July 24, 2012
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signaturesPeter Kabos, Jessica Finlay-Schultz, Chunling Li, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Short-term Topiramate treatment prevents radiation-induced cytotoxic edema in preclinical models of breast-cancer brain metastasisMaria J Contreras-Zárate, Karen Lf Alvarez-Eraso, Jenny A Jaramillo-Gómez, et al.
Pageof 10